Quarterly report pursuant to Section 13 or 15(d)

Equity and Stock-Based Compensation

v3.20.4
Equity and Stock-Based Compensation
3 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Equity and Stock-Based Compensation

6.  Equity and Stock-Based Compensation

 

Stock-based compensation expense was $0.1 million in each of the three months ended December 31, 2020 and 2019.  Stock-based compensation expense is included in selling, general and administrative expenses.

 

The following table summarizes our stock option activity during the three months ended December 31, 2020:

 

 

 

Options

 

 

Weighted

Average

Exercise Price

 

Outstanding at beginning of period

 

 

696,665

 

 

$

7.00

 

Granted

 

 

180,000

 

 

 

5.60

 

Exercised

 

 

(28,250

)

 

 

4.79

 

Forfeited

 

 

(30,665

)

 

 

14.07

 

Outstanding at end of period

 

 

817,750

 

 

$

6.50

 

Exercisable at end of period

 

 

596,002

 

 

$

6.83

 

Weighted average fair value of options granted

   during the period

 

$

2.97

 

 

 

 

 

 

The fair value of options was estimated at the applicable grant date using the Black-Scholes option pricing model with the following assumptions:

 

 

 

Three Months Ended December 31, 2020

 

Risk free interest rate

 

 

1

%

Expected life

 

6 years

 

Dividend rate

 

 

%

Volatility

 

 

58

%

 

On November 29, 2018, we announced that our Board of Directors (the “Board”) approved a stock repurchase program, pursuant to which we were authorized to repurchase up to $4 million of our outstanding common stock, par value $0.01 per share (“Common Stock”), over a one-year period. Repurchases under the program were to be made in open market transactions at prevailing market prices, in privately negotiated transactions, or by other means in compliance with the rules and regulations of the SEC; however, we had no obligation to repurchase shares and the timing, actual number, and value of shares to be repurchased was subject to management’s discretion and depended on the Company’s stock price and other market conditions. Our Board could have terminated the repurchase program at any time while it was in effect.  The term of our repurchase program expired as of the quarter ended December 31, 2019.  There were no shares repurchased under this repurchase program.

 

On February 4, 2020, the Board approved a new stock repurchase program, pursuant to which we may repurchase up to $4 million of our outstanding Common Stock over a one-year period, commencing on February 10, 2020. Repurchases under the program will be made in open market transactions at prevailing market prices, in privately negotiated transactions, or by other means in compliance with the rules and regulations of the SEC;

however, we have no obligation to repurchase shares and the timing, actual number, and value of shares to be repurchased is subject to management’s discretion and will depend on our stock price and other market conditions. We may, in the sole discretion of the Board, terminate the repurchase program at any time while it is in effect. Repurchased shares may be retired or kept in treasury for further issuance. During the quarter ended March 31, 2020, we repurchased 366,000 shares of our Common Stock on the open market at a total cost of approximately $2.0 million (an average price of $5.46 per share). All shares repurchased during the year ended September 30, 2020 have been retired. There were no repurchases during the quarter ended December 31, 2020. Approximately $2 million remain available under the repurchase program as of December 31, 2020.